Zydus Lifesciences Limited (BOM:532321)

Zydus Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	872,304	1,013,630	497,549	356,774	451,368	273,595
Market Cap Growth	40.16%	103.72%	39.46%	-20.96%	64.98%	-22.99%
Enterprise Value	872,559	1,022,435	525,557	387,118	504,363	344,184
Last Close Price	866.65	1002.75	485.75	342.17	430.07	260.57
PE Ratio	19.23	26.26	25.38	7.95	21.16	23.25
PS Ratio	4.39	5.19	2.89	2.36	3.13	1.92
PB Ratio	4.05	4.59	2.53	1.87	3.02	2.34
P/TBV Ratio	7.18	8.48	4.28	3.40	7.04	7.61
P/FCF Ratio	43.67	30.01	39.56	18.50	13.50
P/OCF Ratio	31.40	18.50	16.95	13.70	9.33
EV/Sales Ratio	3.92	5.23	3.05	2.56	3.50	2.42
EV/EBITDA Ratio	13.82	19.45	14.87	12.21	14.77	12.47
EV/EBIT Ratio	15.72	22.53	18.42	15.65	18.44	16.38
EV/FCF Ratio	44.05	31.70	42.92	20.67	16.98
Debt / Equity Ratio	0.01	0.04	0.06	0.22	0.31	0.68
Debt / EBITDA Ratio	0.03	0.16	0.34	1.33	1.35	2.89
Debt / FCF Ratio	-	0.35	0.72	4.68	1.89	3.95
Asset Turnover	-	0.71	0.64	0.59	0.61	0.60
Inventory Turnover	-	1.87	1.81	1.64	1.64	1.86
Quick Ratio	-	1.30	1.05	0.96	0.57	0.62
Current Ratio	-	2.14	1.81	1.54	1.11	1.05
Return on Equity (ROE)	-	18.90%	10.82%	13.96%	16.91%	10.30%
Return on Assets (ROA)	-	10.31%	6.66%	5.98%	7.19%	5.57%
Return on Capital (ROIC)	15.04%	12.95%	8.08%	7.22%	8.71%	6.68%
Return on Capital Employed (ROCE)	-	19.00%	14.10%	12.40%	17.10%	13.60%
Earnings Yield	5.20%	3.81%	3.94%	12.58%	4.73%	4.30%
FCF Yield	2.29%	3.33%	2.53%	5.41%	7.41%
Dividend Yield	0.33%	0.30%	1.23%	0.73%	0.81%	1.34%
Payout Ratio	0.00%	16.09%	13.63%	8.29%	0.07%	60.74%
Buyback Yield / Dilution	0.46%	0.37%	0.79%	-	-	-
Total Shareholder Return	0.79%	0.67%	2.03%	0.73%	0.81%	1.34%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.